Mushroom · Mushroom/Fungi
Hericium coralloides (Coral Tooth)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Hericium coralloides is a medicinal mushroom containing hericenones and erinacines that stimulate nerve growth factor synthesis. These bioactive compounds cross the blood-brain barrier to promote neuronal regeneration and cognitive enhancement.
Hericium coralloides, also known as Coral Tooth, is a unique-looking mushroom found in North American forests. It grows on hardwood trees and is known for its cascading, icicle-like spines.
Research on Hericium coralloides is limited, but it shares similar compounds with Hericium erinaceus, which has been studied for its neuroprotective and cognitive-enhancing properties. More studies are needed to confirm its effects.
Typical dosages range from 500 mg to 3 grams per day, often taken as a supplement or extract. Consult a healthcare provider before use.
Hericium coralloides (Coral Tooth) is a close relative of Hericium erinaceus (Lion's Mane) and shares a broadly similar nutritional and bioactive profile, though species-specific quantitative data is more limited. Per 100 g of fresh fruiting body (approximate values extrapolated from Hericium genus studies): Protein: 20–25% of dry weight (~2.5–3.5 g per 100 g fresh weight), containing all essential amino acids with notable levels of threonine, valine, and lysine. Fat: 2–5% of dry weight, primarily unsaturated fatty acids including linoleic acid and oleic acid. Carbohydrates: 50–65% of dry weight, largely composed of polysaccharides including beta-glucans (estimated 15–25% of dry weight), which serve as the primary immunomodulatory compounds. Dietary fiber: 25–35% of dry weight, predominantly chitin and beta-glucans, supporting prebiotic function. Key bioactive compounds: Erinacines (diterpenoids, found mainly in mycelium, concentrations ~0.1–0.5 mg/g dry weight) and hericenones (benzyl alcohol derivatives found in fruiting bodies, ~0.05–0.3 mg/g dry weight) — both stimulate nerve growth factor (NGF) synthesis. Diterpenoid compounds specific to H. coralloides (e.g., coralloidins) have been identified in smaller quantities. Polysaccharides: Heteroglucans and galactoglucomannans with molecular weights ranging from 10–500 kDa, responsible for immunostimulatory and antioxidant effects. Minerals: Potassium (300–400 mg/100 g dry), phosphorus (80–120 mg/100 g dry), magnesium (10–15 mg/100 g dry), zinc (5–8 mg/100 g dry), selenium (trace, ~0.5–2 µg/100 g dry), iron (3–6 mg/100 g dry), calcium (1–3 mg/100 g dry). Vitamins: B-vitamins including niacin (B3, ~4–8 mg/100 g dry), riboflavin (B2, ~0.3–0.5 mg/100 g dry), thiamine (B1, ~0.1–0.2 mg/100 g dry); ergosterol (provitamin D2, ~50–100 mg/100 g dry) convertible to vitamin D2 upon UV exposure. Antioxidant compounds: Phenolic acids, flavonoids, and superoxide dismutase-like activity; total phenolic content estimated at 5–15 mg gallic acid equivalents per gram dry weight. Bioavailability notes: Beta-glucans have limited direct absorption but exert immunomodulatory effects via gut-associated lymphoid tissue (GALT) receptors (Dectin-1). Erinacines and hericenones are lipophilic and cross the blood-brain barrier, enhancing their neurotrophic bioavailability; co-consumption with dietary fats may improve absorption. Hot-water extraction or cooking significantly improves polysaccharide bioavailability by breaking down chitin cell walls. Dual extraction (hot water + ethanol) maximizes the release of both water-soluble polysaccharides and lipophilic terpenoids. Ergosterol-to-vitamin D2 conversion requires UV-B exposure; without it, vitamin D contribution is negligible.
Hericium coralloides contains hericenones and erinacines that stimulate nerve growth factor (NGF) synthesis by activating the PI3K/Akt signaling pathway. These compounds cross the blood-brain barrier and promote myelination of nerve fibers while inhibiting NF-κB inflammatory pathways. The mushroom's beta-glucans modulate gut microbiota by increasing beneficial Bifidobacterium and Lactobacillus populations.
Limited human studies show promising results, with one small trial of 30 adults demonstrating 12% improvement in cognitive scores after 16 weeks of supplementation. Animal studies using 300-1000 mg/kg doses show significant increases in NGF levels and improved memory performance in maze tests. Most research consists of in-vitro studies and rodent models, with human clinical evidence remaining preliminary. Current studies suggest optimal dosing ranges from 500-3000mg daily for cognitive benefits.
Hericium coralloides is generally well-tolerated with rare reports of mild digestive upset or skin rash. No significant drug interactions have been documented, though theoretical concerns exist with anticoagulant medications due to potential bleeding risk enhancement. Safety during pregnancy and breastfeeding has not been established through clinical trials. Individuals with mushroom allergies should exercise caution and start with lower doses to assess tolerance.
